Exceptional safety reports and contributions to safety sections of regulatory submission documents need the involvement of authors and reviewers who have proven experience in therapeutic areas, regional regulations, and technologies. ClinChoice’s medical writers author and submit high-quality reports using a combination of dependable project management and competent data analysis to provide an additional layer of insight into the product’s safety profile.
The staff oversees the aggregate reporting calendar management, sources line listings, conducts technical and medical reviews, and responds to health authority queries. We have extensive experience in the following report types:
- Development Safety Update Reports (DSURs)
- Investigational New Drug (IND) safety reports
- Periodic Safety Update Reports (PSURs)
- Integrated summaries of safety
- Developmental Risk Management Plan